Trial Outcomes & Findings for Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring (NCT NCT03915717)
NCT ID: NCT03915717
Last Updated: 2024-11-26
Results Overview
Surgeon evaluation of improved monitoring ability via questionnaire with likert scale
TERMINATED
14 participants
Through study completion
2024-11-26
Participant Flow
Participant milestones
| Measure |
EchoMark / EchoSure
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Overall Study
STARTED
|
14
|
|
Overall Study
COMPLETED
|
8
|
|
Overall Study
NOT COMPLETED
|
6
|
Reasons for withdrawal
| Measure |
EchoMark / EchoSure
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Overall Study
EchoMark Not Implanted
|
6
|
Baseline Characteristics
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
Baseline characteristics by cohort
| Measure |
EchoMark / EchoSure
n=14 Participants
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Age, Continuous
|
64 Years
n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
14 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Through study completionPopulation: Surgeon Evaluation Questionnaire was not completed, Data was not collected.
Surgeon evaluation of improved monitoring ability via questionnaire with likert scale
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Through study completion, an average of 1 yearPopulation: Surgeon Satisfaction Survey was not completed. Data not collected.
Surgeon evaluation of satisfaction via questionnaire with likert scale
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Through patient stay, up to 5 days post-opPercentage of flaps that fail
Outcome measures
| Measure |
EchoMark / EchoSure
n=8 Participants
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Flap Failure Rate
|
0 Flaps that Failed
|
SECONDARY outcome
Timeframe: Through patient stay, up to 5 days post-opPercentage of flaps that require return to the OR after the baseline procedure through 5 days post-op.
Outcome measures
| Measure |
EchoMark / EchoSure
n=8 Participants
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Flap Takeback Rate
|
0 Flaps that Required Return to the OR
|
SECONDARY outcome
Timeframe: Through patient stay, up to 5 days post-opPercentage of flaps that require salvage after the baseline procedure
Outcome measures
| Measure |
EchoMark / EchoSure
n=8 Participants
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Flap Salvage Rate
|
0 Number of Flaps that Require Salvage
|
SECONDARY outcome
Timeframe: Through patient stay, up to 5 days post-opPopulation: Data was not collected on hospitalization costs.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Through patient stay, up to 5 days post-opNumber of hours from when the subject's baseline procedure ends until a secondary trip to the OR if required.
Outcome measures
| Measure |
EchoMark / EchoSure
n=8 Participants
Patients undergoing free flap surgery and have an EchoMark soft tissue marking device placed and monitored with the EchoSure.
|
|---|---|
|
Time From OR Departure to Return to OR
|
NA Hours
Time to return to OR cannot be calculated due to insufficient number of participants with events
|
SECONDARY outcome
Timeframe: Through study completion, an average of 1 yearPopulation: The Nurse Questionnaire was not completed. Data was not collected.
Outcome measures
Outcome data not reported
Adverse Events
EchoMark / EchoSure
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place